BeStock  
Stocks › Biotechnology › PHAT

Phathom Pharmaceuticals PHAT

US equityMarket cap rank #3679Biotechnology
$6.81 +$0.03 (+0.44%)
Market closed · Oct 8, 7:20 am ET · Last extended-hours $6.80 -0.15%
Open$6.87
Prev close$6.78
Day range$6.60 – $7.03
Volume1.63M
Market cap$550.94M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±8.2%last 11 reports
Closed higher4 of 1136% of the time
Best reaction+10.1%
Worst reaction-22.4%

Stock move on the day after each report

-6.6%2023/Q4-0.1%2024/Q1+8.7%2024/Q2+2.8%2024/Q3-3.0%2024/Q4-21.7%2025/Q1+8.3%2025/Q2-1.6%2025/Q3+10.1%2025/Q4-4.9%2026/Q1-22.4%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q230 Jul 2026Pre Market±26.8%-22.42%Within range
2026/Q130 Apr 2026Pre Market±23.9%-4.92%Within range
2025/Q426 Feb 2026Pre Market±32.7%+10.06%Within range
2025/Q330 Oct 2025Pre Market±30.0%-1.63%Within range
2025/Q27 Aug 2025Pre Market±36.7%+8.29%Within range
2025/Q11 May 2025None±34.8%-21.68%Within range
2024/Q46 Mar 2025None±37.2%-2.96%Within range
2024/Q37 Nov 2024Pre Market±21.9%+2.78%Within range
2024/Q28 Aug 2024Pre Market±28.1%+8.70%Within range
2024/Q19 May 2024Pre Market±20.0%-0.10%Within range
2023/Q47 Mar 2024Pre Market–-6.58%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$74.27M+88.0% YoY
Operating profit-$3.97M+93.4% YoY
Net profit-$17.58M+76.8% YoY
Diluted EPS-$0.21+80.0% YoY
Free cash flow-$1.97M+96.9% YoY
Operating cash flow-$1.93M

Revenue, last 8 quarters

$16.4MSep '24$29.7MDec '24$28.5MMar '25$39.5MJun '25$49.5MSep '25$57.6MDec '25$58.3MMar '26$74.3MJun '26

Net profit, last 8 quarters

$-85.6MSep '24$-74.5MDec '24$-94.3MMar '25$-75.8MJun '25$-30.0MSep '25$-21.1MDec '25$-30.4MMar '26$-17.6MJun '26

Profitability & balance sheet

Gross margin82.9%
Operating margin-17.0%
Net margin-41.3%
Return on assets-34.3%
Current ratio1.92
Liabilities / assets205.3%
Cash & investments$182.48M
Total debt$166.44M
Net cash (debt)$16.04M

Discussion

No comments yet — be the first to weigh in on PHAT.

Leave a comment

Scroll to Top